Inactivation of hnRNPU in liver cells exacerbates HFD-induced NASH by inducing a truncated form of the tyrosine kinase receptor B (TrkB), which promotes liver inflammation, hepatocyte death, and fibrosis [84]. Here, NTRK2 is linked to metabolic dysfunction-associated steatohepatitis.